Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia.

Ni Luh Ayu MegasariLaura Navika YamaniJuniastuti JuniastutiMaria Inge LusidaYasuko Mori

Published in: PeerJ (2023)

Different vaccines might produce different antibody responses. Adopting a stronger policy regarding the administration of booster doses might be beneficial to elicit positive anti-S-IgG antibodies, especially among older individuals, those with comorbid diseases, and those with a longer time after the second vaccination dose.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
public health
healthcare